Algo version: 0.98b
Enfusion, Inc. is listed at the NYSE Exchange
Enfusion, Inc. [ENFN]
NYSE Sector: Technology Industry:Software - Application

Is Enfusion, Inc. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Enfusion, Inc. 10 years ago, but if you had invested on Thursday 21st of October 2021 when the price was $19.81, you would have made a loss of $-11.76 per share or -59.36%

Yes, the average daily trading liquidity for Enfusion, Inc. is $378 990 thousand. You should therefore be able to get in and out of your positions relatively fast.

Enfusion, Inc. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.62, the company's ability to pay off the debt is good. The company has a very low net profit margin of 1.40%, which is challenging.

We have calculated the inflation risk for Enfusion, Inc. to be low [0.35 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.